Chick-fil-A, the popular fast-food chain known for its chicken sandwiches, made headlines recently with its decision to change its chicken sourcing and antibiotics policy. The company announced that it will be transitioning from using No Antibiotics Ever (NAE) chicken to No Antibiotics Important to Human Medicine (NAIHM) chicken starting this spring. This shift aims to ensure a reliable supply of high-quality chicken while still maintaining a focus on antibiotic usage.
Customers who received the announcement through the Chick-fil-A app were informed about the change and the reasons behind it. While NAE chicken guarantees that no antibiotics were used in raising the animals, NAIHM restricts the use of antibiotics important to human medicine and only allows the use of animal antibiotics in case of sickness.
The decision to make this change comes shortly after a recall of Polynesian sauce dipping cups due to allergy concerns, leading to some speculation about the company’s quality control measures. However, Chick-fil-A emphasized that the shift in policy is aimed at ensuring the continued high quality of their chicken products.
Overall, this move by Chick-fil-A has raised discussions about antibiotic usage in the poultry industry and how fast-food chains can balance quality, sustainability, and consumer expectations in their sourcing practices.
#ChickfilA #AntibioticsPolicy #ChickenSourcing